Skip to main content

Closed

MREO: Mereo BioPharma Group plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin-7531.1%

ROIC-109.1%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-397.1×

Current ratio6.48×

Mereo BioPharma Group plc

MREONASDAQ Global Market·USD·Closed

Mereo BioPharma Group plc

MREONASDAQ·USD·Closed

$0.34

+8.79%

$0.34

+$0.03 (8.79%)

52W Range

7thpctl

Volume

0.82×avg

Mkt Cap

54.70MUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.82×avg

Market Cap

54.70MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings